BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16101615)

  • 1. Initial Asian experience in hysteroscopic sterilisation using the Essure permanent birth control device.
    Chern B; Siow A
    BJOG; 2005 Sep; 112(9):1322-7. PubMed ID: 16101615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The feasibility, success and patient satisfaction associated with outpatient hysteroscopic sterilisation.
    Sinha D; Kalathy V; Gupta JK; Clark TJ
    BJOG; 2007 Jun; 114(6):676-83. PubMed ID: 17516957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Female sterilisation: a cohort controlled comparative study of ESSURE versus laparoscopic sterilisation.
    Duffy S; Marsh F; Rogerson L; Hudson H; Cooper K; Jack S; Hunter D; Philips G
    BJOG; 2005 Nov; 112(11):1522-8. PubMed ID: 16225573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placement of a permanent birth control device at a university medical center.
    Shavell VI; Abdallah ME; Diamond MP; Berman JM
    J Reprod Med; 2009 Apr; 54(4):218-22. PubMed ID: 19438163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-Essure hysterosalpingography compliance in a clinic population.
    Shavell VI; Abdallah ME; Diamond MP; Kmak DC; Berman JM
    J Minim Invasive Gynecol; 2008; 15(4):431-4. PubMed ID: 18588851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective analysis of office-based hysteroscopic sterilization.
    Levie MD; Chudnoff SG
    J Minim Invasive Gynecol; 2006; 13(2):98-101. PubMed ID: 16527710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permanent sterilization for the 21st century using the hysteroscopic approach.
    Collins GM; Herbst SJ; Aqua KA
    Surg Technol Int; 2004; 13():115-9. PubMed ID: 15744682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of hysteroscopic Essure(®) sterilisation: report on 4306 procedures performed in a single centre.
    Povedano B; Arjona JE; Velasco E; Monserrat JA; Lorente J; Castelo-Branco C
    BJOG; 2012 Jun; 119(7):795-9. PubMed ID: 22360159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essure: a new device for hysteroscopic tubal sterilization in an outpatient setting.
    Ubeda A; Labastida R; Dexeus S
    Fertil Steril; 2004 Jul; 82(1):196-9. PubMed ID: 15237011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report of failed tubal occlusion using Essure pbc (permanent birth control) hysteroscopic sterilisation procedure.
    Karthigasu KA; Garry R; Hart R
    Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):365-7. PubMed ID: 16866803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hysteroscopic female sterilization with Essure in an outpatient setting.
    Andersson S; Eriksson S; Mints M
    Acta Obstet Gynecol Scand; 2009; 88(6):743-6. PubMed ID: 19412802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Essure placement in intrauterine device users.
    Mascaro M; Mariño M; Vicens-Vidal M
    J Minim Invasive Gynecol; 2008; 15(4):485-90. PubMed ID: 18602048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in sterilization since the introduction of Essure hysteroscopic sterilization.
    Shavell VI; Abdallah ME; Shade GH; Diamond MP; Berman JM
    J Minim Invasive Gynecol; 2009; 16(1):22-7. PubMed ID: 18996773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of adverse events with Essure hysteroscopic sterilization reported to the Manufacturer and User Facility Device Experience database.
    Al-Safi ZA; Shavell VI; Hobson DT; Berman JM; Diamond MP
    J Minim Invasive Gynecol; 2013; 20(6):825-9. PubMed ID: 24183273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placement of the Essure permanent birth control device with fluoroscopic guidance: a novel method for tubal sterilization.
    McSwain H; Shaw C; Hall LD
    J Vasc Interv Radiol; 2005 Jul; 16(7):1007-12. PubMed ID: 16002509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of hysteroscopic sterilization performed in-office versus a hospital operating room.
    Nichols M; Carter JF; Fylstra DL; Childers M;
    J Minim Invasive Gynecol; 2006; 13(5):447-50. PubMed ID: 16962530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and effectiveness of a new hysteroscopic method for permanent birth control: results of the first Essure pbc clinical study.
    Kerin JF; Carignan CS; Cher D
    Aust N Z J Obstet Gynaecol; 2001 Nov; 41(4):364-70. PubMed ID: 11787907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essure Permanent Birth Control, Effectiveness and Safety: An Italian 11-Year Survey.
    Franchini M; Zizolfi B; Coppola C; Bergamini V; Bonin C; Borsellino G; Busato E; Calabrese S; Calzolari S; Fantin GP; Giarrè G; Litta P; Luerti M; Mangino FP; Marchino GL; Molinari MA; Scatena E; Scrimin F; Telloli P; Di Spiezio Sardo A
    J Minim Invasive Gynecol; 2017; 24(4):640-645. PubMed ID: 28232037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Essure--a novel method of sterilization].
    Revel A; Nadjary M; Shushan A
    Harefuah; 2008 Feb; 147(2):107-10, 184. PubMed ID: 18357664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unilateral placement of the Adiana device after failed bilateral placement of the Essure device for hysteroscopic sterilization.
    Gimpelson RJ; Wagner CA
    J Minim Invasive Gynecol; 2010; 17(5):660-1. PubMed ID: 20728829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.